Phathom Pharmaceuticals (PHAT) Debt to Equity Ratio
Price: $6.485
Market Cap: $451.60M
Avg Volume: 1.12M
Market Cap: $451.60M
Avg Volume: 1.12M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Debt to Equity Ratio
Phathom Pharmaceuticals's debt to equity ratio indicates the proportion of equity and debt the company uses to finance its assets:
- Annual: 0.00
- Quarterly: -0.80
- TTM: -0.80
Other Key Debt Metrics
These metrics provide additional insights into Phathom Pharmaceuticals's financial leverage and its ability to meet financial obligations:
- Debt Ratio - indicates the proportion of a company's assets that are financed through debt:
- Annual: 0.13%
- Quarterly: 53.37%
- TTM: 53.37%
- Debt to Assets Ratio - shows the proportion of a company's assets that are financed by debt:
- Annual: 0.13%
- Quarterly: 53.37%
- TTM: 53.37%
These financial metrics offer a comprehensive view of Phathom Pharmaceuticals's debt structure and financial health. By comparing these ratios with industry benchmarks, investors can better understand the company's leverage and risk profile.
Annual Debt to Equity Ratio
0.00
Quarterly Debt to Equity Ratio
-0.80
TTM Debt to Equity Ratio
-0.80
Phathom Pharmaceuticals Historical Debt to Equity Ratio
Historical Debt Ratio
Historical Debt to Assets Ratio
Phathom Pharmaceuticals Historical Debt to Equity Ratio
The table below shows various debt metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | Debt to Equity Ratio | Debt Ratio | Debt to Assets Ratio |
|---|---|---|---|
| 2024 | 0.00 | 0.13% | 0.13% |
| 2023 | -1.91 | 33.59% | 33.59% |
| 2022 | -1.30 | 58.90% | 58.90% |
| 2021 | 1.27 | 48.22% | 48.22% |
| 2020 | 0.25 | 16.61% | 16.61% |
| 2019 | 0.10 | 9.17% | 9.17% |
| 2018 | -1.52 | 216.19% | 216.19% |
Related Metrics
Explore detailed financial metrics and analysis for PHAT.